Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9613
Title: Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort
Authors: Kalyoncu, U.
Solmaz, D.
Emmungil, H.
Yazici, A.
Kasifoglu, T.
Kimyon, G.
Balkarlı, Ayşe
Keywords: Adult-onset Still's disease
Disease modifying anti-rheumatic drugs
Disease pattern
Remission
corticosteroid
disease modifying antirheumatic drug
hydroxychloroquine
methotrexate
antiinflammatory agent
biological marker
adult
adult onset Still disease
arthralgia
arthritis
Article
chronic disease
clinical feature
cohort analysis
delayed diagnosis
drug megadose
female
fever
follow up
hepatomegaly
human
laboratory test
lymphadenopathy
major clinical study
male
medical record review
multicenter study
myalgia
onset age
outcome assessment
pericarditis
pleurisy
priority journal
rash
remission
sore throat
splenomegaly
treatment failure
treatment response
adolescent
aged
clinical trial
combination drug therapy
middle aged
phenotype
recurrent disease
risk factor
Still's Disease, Adult-Onset
treatment outcome
very elderly
young adult
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents
Biomarkers
Delayed Diagnosis
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Phenotype
Recurrence
Remission Induction
Risk Factors
Treatment Outcome
Young Adult
Publisher: Academic Press
Abstract: Background: Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices are frequently dependent on expert opinions. The objectives of the present study were to assess treatment modalities, disease course, and the factors influencing the outcome of patients with AOSD. Methods: A multicenter study was used to reach sufficient patient numbers. The diagnosis of AOSD was based on the Yamaguchi criteria. The data collected included patient age, gender, age at the time of diagnosis, delay time for the diagnosis, typical AOSD rash, arthralgia, arthritis, myalgia, sore throat, lymphadenopathy, hepatomegaly, splenomegaly, pleuritis, pericarditis, and other rare findings. The laboratory findings of the patients were also recorded. The drugs initiated after the establishment of a diagnosis and the induction of remission with the first treatment was recorded. Disease patterns and related factors were also investigated. A multivariate analysis was performed to assess the factors related to remission. Results: The initial data of 356 patients (210 females; 59%) from 19 centers were evaluated. The median age at onset was 32 (16-88) years, and the median follow-up time was 22 months (0-180). Fever (95.8%), arthralgia (94.9%), typical AOSD rash (66.9%), arthritis (64.6%), sore throat (63.5%), and myalgia (52.8%) were the most frequent clinical features. It was found that 254 of the 306 patients (83.0%) displayed remission with the initial treatment, including corticosteroids plus methotrexate with or without other disease-modifying antirheumatic drugs. The multivariate analysis revealed that the male sex, delayed diagnosis of more than 6 months, failure to achieve remission with initial treatment, and arthritis involving wrist/elbow joints were related to the chronic disease course. Conclusion: Induction of remission with initial treatment was achieved in the majority of AOSD patients. Failure to achieve remission with initial treatment as well as a delayed diagnosis implicated a chronic disease course in AOSD. © 2016 Elsevier Ltd.
URI: https://hdl.handle.net/11499/9613
https://doi.org/10.1016/j.jaut.2016.02.010
ISSN: 0896-8411
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

67
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

66
checked on Jul 10, 2024

Page view(s)

20
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.